Publication | Closed Access
Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study
532
Citations
10
References
2009
Year
OncologyFirst-line BevacizumabGastrointestinal OncologyMedicineColorectal CancerMetastatic Colorectal CancerPharmacotherapyAnti-cancer AgentCancer TreatmentPharmacologyRadiation OncologyCancer ResearchBeat Study
| Year | Citations | |
|---|---|---|
Page 1
Page 1